Subscribe To Our Free Newsletter |
Buy Aurobindo Pharma, target price Rs 675 : Anand Rathi
For the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 6276.54 crore, up 7.14 per cent as compared to last quarter total income of Rs 5858.25 crore and up 8.53 per cent from last year same quarter total income of Rs 5783.29 crore.